BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities

What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...

May 17, 2023 | News

Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment

MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...

May 02, 2023 | News

Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia

Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and ma...

April 26, 2023 | News

Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer announced that Clev...

April 18, 2023 | News

Emmes' Acquisition of Essex Management Boosts Its Technology Prowess to Help Solve Global Health Challenges

Biopharma APAC sat down with Matt Honan (MH), Vice president and global head of corporate development at Emmes and Ching Tian (CT), Chief In...

April 06, 2023 | Influencers

TransCure bioServices expands their team to lead the way in animal welfare

TransCure bioServices, a unique fee-for-service Humanized Mouse Preclinical CRO, has announced two new additions to their workforce to further improve thei...

April 04, 2023 | News

ABIONYX Pharma Unveils Ophthalmology Strategy and Positive Preclinical Results for Innovative Technologies.

Very promising preclinical results of the apoA-I biovector in an acute inflammation model Development of safe corticoids to limit traditional corticoid-...

April 01, 2023 | News

Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18

Remedium’s lead candidate is the only disease modifying gene therapy based on the clinically proven regenerative mechanism of FGF18. OA is the larges...

March 30, 2023 | News

Thermo Fisher Scientific Selected to Support National Institute of Health’s Blueprint MedTech program

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a five-year contract to provide ...

February 21, 2023 | News

Beyond Traditional Placebo Controls in Rare Disease Clinical Trials

The Collaborative Trajectory Analysis Project (cTAP), a global coalition in rare disease, has announced evidence to support patient-centric alternativ...

February 08, 2023 | News

GenScript is increasing its capacity for producing cGMP sgRNA and non-viral DNA payloads in order to keep project wait times to a minimum.

How is GenScript planning to meet the growing demand for cell and gene therapies in 2023? GenScript is committed to advancing non-viral gene and cell ther...

February 01, 2023 | Influencers